The company believes sales of the drug will rise sharply
|
A Borders pharmaceutical firm has been cleared to market an anti-sickness drug in the UK and Germany.
Galashiels-based ProStrakan has estimated the total value of the German market could be more than £10m.
It already sells the drug - designed to treat post-operative nausea - in eight other European countries.
Sales of xomolix totalled £4.2m in 2007 and the company believes there is a "substantial level" of demand for the product in the new nations.
A total of eight countries are involved in the new marketing clearance.
|
Bookmark with:
What are these?